Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB 80802 (Alliance) (C8)
         Google Scholar   
Citation:
J Clin Oncol vol 36 (15_suppl) e16107
Meeting Instance:
ASCO 2018
Year:
2018
Type:
Abstract
Sub type:
Published Only
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3009  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10CA077202, U10CA180820, U10CA180888  
Corr. Author:
 
Authors:
                                         
Networks:
BAPTIST, CA824, COLUMBIA, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY016, MN022, MONTEFIORE, NY021, PA121   
Study
CALGB-80802
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: